In the latest trading session, 0.62 million Dexcom Inc (NASDAQ:DXCM) shares changed hands as the company’s beta touched 1.18. With the company’s most recent per share price at $72.43 changed hands at -$0.65 or -0.88% at last look, the market valuation stands at $29.03B. DXCM’s current price is a discount, trading about -96.05% off its 52-week high of $142.00. The share price had its 52-week low at $62.34, which suggests the last value was 13.93% up since then. When we look at Dexcom Inc’s average trading volume, we note the 10-day average is 3.86 million shares, with the 3-month average coming to 5.88 million.

Analysts gave the Dexcom Inc (DXCM) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.56. If we narrow down to specifics, the data shows that 0 out of 12 analysts rate the stock as a Sell, with a further 1 assigning it an Overweight rating. Of the remaining, 1 recommended DXCM as a Hold, 10 felt it is a Buy and 0 rated the stock as Underweight. Dexcom Inc’s EPS for the current quarter is expected to be 0.43.

Dexcom Inc (NASDAQ:DXCM) trade information

Instantly DXCM was in red as seen in intraday trades today. With action 3.63%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -41.63%, with the 5-day performance at 3.63% in the green. However, in the 30-day time frame, Dexcom Inc (NASDAQ:DXCM) is 5.50% up. Looking at the short shares, we see there were 9.55 million shares sold at short interest cover period of 2.34 days.

The consensus price target for the stock as assigned by Wall Street analysts is 95, meaning bulls need an upside of 23.76% from its recent market value. According to analyst projections, DXCM’s forecast low is 28.125 with 146 as the target high. To hit the forecast high, the stock’s price needs a -101.57% plunge from its current level, while the stock would need to tank 61.17% for it to hit the projected low.

Dexcom Inc (DXCM) estimates and forecasts

Data shows that the Dexcom Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -47.46% over the past 6 months, a 11.18% in annual growth rate that is considerably lower than the industry average of 13.80%. Year-over-year growth is forecast to reach 10.80% up from the last financial year.

Consensus estimates given by 22 financial analysts project the company’s revenue in the current quarter to hit an average of 990.71M. 21 analysts are of the opinion that Dexcom Inc’s revenue for the current quarter will be 1.1B. The estimates for the next quarter sales put growth at 6.20%.

The 2024 estimates are for Dexcom Inc earnings to increase by 11.45%, but the outlook for the next 5-year period is at 23.00% per year.

DXCM Dividends

Dexcom Inc is expected to release its next quarterly earnings report on 2024-Oct-24.

Dexcom Inc (NASDAQ:DXCM)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 0.31% of Dexcom Inc shares while 98.09% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 98.39%. There are 98.09% institutions holding the Dexcom Inc stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 11.9203% of the shares, roughly 46.51 million DXCM shares worth $5.27 billion.

BLACKROCK INC. holds the second largest percentage of outstanding shares, with 8.8466% or 34.52 million shares worth $3.91 billion as of 2024-06-30.

Among Mutual Funds, the top two as of Jun 30, 2024 were Vanguard Total Stock Market Index Fund and Vanguard 500 Index Fund. With 12.58 shares estimated at $910.87 million under it, the former controlled 3.14% of total outstanding shares. On the other hand, Vanguard 500 Index Fund held about 2.55% of the shares, roughly 10.21 shares worth around $739.33 million.